Ischaemic stroke
Not yet recruitingPhase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke
- Disease:Ischaemic stroke
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Takeda Development Center Americas Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany322 clinical trials in Goettingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on acute cerebral ischemic stroke treatment and groundbreaking studies in Alzheimer's Disease management, evaluating novel therapeutic approaches for improving patient outcomes.
Clinical trials examining the safety and efficacy of targeted therapies for acute neurological conditions.
Comprehensive studies in various cancer types, including lymphoma and lung cancer, with particular focus on targeted therapies and innovative treatment combinations.
Evaluating novel therapeutic approaches for both rare and common cancer types.
Advanced research in eye disorders, particularly focusing on thyroid eye disease and geographic atrophy, exploring new treatment modalities and therapeutic antibodies.
Investigating breakthrough treatments for both rare and common eye conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.